Literature DB >> 2533223

Impact of acute and chronic sodium loading on atrial natriuretic peptide and renin in man.

G Wambach1, M Stimpel, G Bönner, S Degenhardt, W Kaufmann.   

Abstract

The relationship between the renin-angiotensin system and the atrial natriuretic peptide and its contributions to the control of sodium balance is not clarified. We therefore studied plasma renin concentration (PRC) and plasma levels of atrial natriuretic peptide (ANP) in normal subjects during acute and chronic salt loading. Acute intravascular volume expansion by iv infusion of 2000 ml of normal saline resulted in sharp rise in plasma ANP from 122 +/- 24 to 405 +/- 141 pg/ml (p less than 0.05). This increase was only transient with plasma ANP returning to control levels after 240 min. In contrast, reduction in plasma renin concentration was less pronounced, however it was persistent for up to 240 min paralleled by a reduction in plasma protein. Reciprocal changes in ANP plasma levels and PRC were observed during dietary modification in sodium intake. At the end of low sodium diet over 4 days, supine plasma ANP averaged 49 +/- 7 pg/ml and levels increased to 128 +/- 38 pg/ml after 6 days of high sodium intake in 11 healthy subjects (p less than 0.05). In contrast, PRC values averaged 69.8 +/- 19.8 microU/ml and 14.4 +/- 6.5 microU/ml during low and high sodium diet respectively (p less than 0.01). The inverse relation between PRC and ANP was seen after prolonged dietary sodium loading over 15 days in 8 additional subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2533223     DOI: 10.1007/BF03350033

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Emergence of a new cardiovascular control system: atrial natriuretic factor. An introduction.

Authors:  E H Blaine
Journal:  Clin Exp Hypertens A       Date:  1985

Review 2.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.

Authors:  J H Laragh
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

3.  Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats.

Authors:  T Yamada; K Nakao; N Morii; H Itoh; S Shiono; M Sakamoto; A Sugawara; Y Saito; H Ohno; A Kanai
Journal:  Eur J Pharmacol       Date:  1986-06-24       Impact factor: 4.432

4.  Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.

Authors:  T Maack; D N Marion; M J Camargo; H D Kleinert; J H Laragh; E D Vaughan; S A Atlas
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

5.  Inhibition of aldosterone biosynthesis by atriopeptins in rat adrenal cells.

Authors:  W B Campbell; M G Currie; P Needleman
Journal:  Circ Res       Date:  1985-07       Impact factor: 17.367

6.  Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loading.

Authors:  J Weil; R E Lang; H Suttmann; U Rampf; F Bidlingmaier; R Gerzer
Journal:  Klin Wochenschr       Date:  1985-12-16

7.  Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process.

Authors:  A Kurtz; R Della Bruna; J Pfeilschifter; R Taugner; C Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Effects of synthetic atrial natriuretic factor on renal function and renin release.

Authors:  J C Burnett; J P Granger; T J Opgenorth
Journal:  Am J Physiol       Date:  1984-11

9.  Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man.

Authors:  P Weidmann; B Hellmueller; D E Uehlinger; R E Lang; M P Gnaedinger; L Hasler; S Shaw; C Bachmann
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

Review 10.  Atrial natriuretic peptide: a new factor in blood pressure control.

Authors:  R E Lang; T Unger; D Ganten
Journal:  J Hypertens       Date:  1987-06       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.